CYTOKINETICS INC — Director's Dealing 2023

Feb 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2023-02-03

Reporting Person: Jaw Ching (SVP Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-03	Common Stock	M	15000	$12.10	Acquired	82184	Direct
2023-02-03	Common Stock	S	15000	$45.00	Disposed	67184	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-03	Incentive Stock Option (Right to Buy)	$12.10	M	15000	Disposed	2027-06-30	Common Stock (15000)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2022.